Where we unite to #EndTB!

Subscribe to the TB WIRE today!

​​​​​​​​​​​​​​​​Peer-Reviewed Publications​​​​

• Treatment outcomes of multidrug-resistant TB with selective use of new drugs
  
• Clinical utility of target-based next-generation sequencing for drug-resistant TB
  
• Concordance of three approaches for operationalizing outcome definitions for multidrug-resistant TB
  
• Introduction of the Simple One-Step stool Xpert Ultra method to detect TB in children and adults
  
• Sugar and sugar-free liquid formulations of delamanid for patients with rifampicin-resistant TB
  
• Reduced vitamin D-induced cathelicidin production and killing of Mycobacterium tuberculosis in macrophages from a patient with a non-functional vitamin D receptor: A case report
  
• Yield of facility-based targeted universal testing for tuberculosis (TUTT) with Xpert and mycobacterial culture in high-risk groups attending primary care facilities in South Africa 
  
• Pro-Inflammatory Alterations of Circulating Monocytes in Latent Tuberculosis Infection 
  
• The effect of undernutrition on sputum culture conversion and treatment outcomes among people with multidrug-resistant tuberculosis: a systematic review and meta-analysis
  
• ​T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection
  
• Multicomponent strategy with decentralised molecular testing for tuberculosis in Uganda: a cost and cost-effectiveness analysis
  
• Mucosal exposure to non-tuberculous mycobacteria elicits B cell-mediated immunity against pulmonary tuberculosis
  
• ​Extemporaneously compounded liquid formulations of clofazimine
  
• Diabetes characteristics and long-term management needs in diabetic TB patients
  
• The impact of time at home on potential yield of home-based TB contact investigation
  
• Factors associated with false-negative for T-SPOT.TB in patients with TB disease
  
• Therapeutic drug monitoring and TB treatment outcomes in patients with diabetes mellitus
  
• Diabetes mellitus is not a predictor of poor TB treatment outcomes
  
• Effect of BCG on Respiratory Complications Caused by COVID-19: A Scoping Review
  
• Improving cascade outcomes for active TB: A global systematic review and meta-analysis of TB interventions
  
• Epidemiology of tuberculosis and susceptibility to antituberculosis drugs in Reunion Island
  
• Identification of host biomarkers from dried blood spots for monitoring treatment response in extrapulmonary tuberculosis
  
• ​More than Mycobacterium tuberculosis: site-of-disease microbial communities, and their functional and clinical profiles in tuberculous lymphadenitis 
  
• Mycobacterium tuberculosis senses host Interferon-γ via the membrane protein MmpL10
  
• ​Catheter-Related Bloodstream Infection Caused by Mycolicibacterium iranicum, California, USA
  
• Listeria-vectored multi-antigenic tuberculosis vaccine protects C57BL/6 and BALB/c mice and guinea pigs against Mycobacterium tuberculosis challenge
  
• Bacteriophages of Mycobacterium tuberculosis, their diversity, and potential therapeutic uses: a review
  
• A comprehensive update to the Mycobacterium tuberculosis H37Rv reference genome
  
• Effect of teriparatide on drug treatment of tuberculous spondylitis: an experimental study
  
• Metallodendrimer-sensitised Cytochrome P450 3A4 Electrochemical Biosensor for TB Drugs
  
• Tuberculosis treatment failure associated with evolution of antibiotic resilience
  
• Impact of Undernutrition on Tuberculosis Treatment Outcomes in India: A Multicenter, Prospective, Cohort Analysis Get access Arrow
  
• Selection bias in multidrug-resistant tuberculosis cohort studies assessing sputum culture conversion
  
• ​Caregivers’ perspectives on health-related quality of life in young children with TB and respiratory illnesses
  
• Facilitators and barriers to TB care during the COVID-19 pandemic
  
• Reasons for missed opportunities to screen and test for TB in healthcare facilities
  
• Reasons for poor uptake of TB preventive therapy in South Africa
  
• Breakthrough TB among people living with HIV on TB preventive therapy
  
• Causes of pre-treatment loss to follow-up in patients with TB
  
• A high-resolution 3D atlas of the spectrum of tuberculous and COVID-19 lung lesions
  
• Using the Food and Drug Administration´s Sentinel System for surveillance of TB infection
  
• The household economic burden of drug-susceptible TB diagnosis and treatment in The Gambia
  
• eHealth in TB clinical management
  
• Finding the missing children for TB care and prevention in Kenya
  
• Potential drug–drug interactions among hospitalised TB patients
  
• Efficiency of TB service provision in the public and private health sectors in Ethiopia
  
• Stable sugar and sugar-free suspensions of pretomanid
  
• ​Effect of Gender on Clinical Presentation of Tuberculosis (TB) and Age-Specific Risk of TB, and TB-Human Immunodeficiency Virus Coinfection 
  
• Low dose Linezolid for Treatment of Patients with Multidrug-resistant (MDR) Tuberculosis (TB) 
  
•  The Value of Chest Radiography in Tuberculosis Preventive Treatment Screening in Children and Adolescents
  
• COVID-19 and global childhood tuberculosis notifications
  
• Global impact of COVID-19 on childhood tuberculosis: an analysis of notification data
  
• Inequalities in the impact of COVID-19-associated disruptions on tuberculosis diagnosis by age and sex in 45 high TB burden countries
  
• Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial
  
• Lifesaving, cost-saving: Innovative simplified regimens for drug-resistant tuberculosis
  
• Mutation detection and minimum inhibitory concentration determination against linezolid and clofazimine in confrmed XDR-TB clinical isolates
  
• Safety and Effectiveness Outcomes From a 14-Country Cohort of Patients With Multi-Drug Resistant Tuberculosis Treated Concomitantly With Bedaquiline, Delamanid, and Other Second-Line Drugs
  
• Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment (SMARTT): a study protocol for a phase IV pragmatic randomized controlled patient management strategy trial
  
• Mitochondrial ROS promotes susceptibility to infection via gasdermin D-mediated necroptosis
  
• Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infants
  
• Effect of active tuberculosis on the survival of HIV-infected adult patients who initiated antiretroviral therapy at public hospitals of Eastern Ethiopia: A retrospective cohort study
  
• What’s New in Childhood Tuberculosis?
  
• Association of Treated and Untreated Chronic Hepatitis C With the Incidence of Active Tuberculosis Disease: A Population-Based Cohort Study Get access Arrow
  
• Quantification of multidrug-resistant M. tuberculosis bacilli in sputum during the first 8 weeks of treatment
  
• TB in migrants residing in the Netherlands for at least 5 years at diagnosis, 2003–2018
  
• Patterns and characteristics of TB among key risk groups in Canada, 1993–2018
  
• Factors influencing treatment outcomes in patients with isoniazid-resistant pulmonary TB
  
• A scoping review of interventions to mitigate common non-communicable diseases among people with TB
  
• Cost of TB services: approach and summary findings of a multi-country study (Value TB)
  
• Implementing tuberculosis patient cost surveys in resource-constrained settings: lessons from Tanzania
  
• A comprehensive update to the Mycobacterium tuberculosis H37Rv reference genome
  
• Effect of systematic tuberculosis detection on mortality in young children with severe pneumonia in countries with high incidence of tuberculosis: a stepped-wedge cluster-randomised trial
  
• Disseminated Tuberculosis Post COVID-19 Infection: A Case Report
  
• Abnormal Presentation of Extrapulmonary Tuberculosis
  
• Cost effectiveness analysis of single and sequential testing strategies for tuberculosis infection in adults living with HIV in the United States
  
• Community- vs. hospital-based management of multidrug-resistant TB in Pakistan
  
• The economic burden of TB faced by patients and affected families in Papua New Guinea
  
• Country differences and determinants of yield in programmatic migrant TB screening in four European countries
  
• Caregiver willingness to give TPT to children living with drug-resistant TB patients
  
• TB screening, prevention and treatment cascade in a Malawi prison
  
• Budget impact of next-generation sequencing for diagnosis of TB drug resistance in Moldova
  
• A 2020 baseline assessment for the monitoring of the End TB indicator of catastrophic costs in Burkina Faso
  
• Family directly observed therapy for children with drug-resistant TB
  
• Updated guidelines for child and adolescent TB
  
• Effectiveness of a community-based intervention to prevent childhood TB in Lesotho
  
• Isoniazid preventive therapy among child contacts of TB patients, India
  
• Bedaquiline for multidrug-resistant TB in paediatric patients
  
• Childhood TB in China: notification, characteristics and risk factors for outcomes, 2010–2017
  
• Evybactin is a DNA gyrase inhibitor that selectively kills Mycobacterium tuberculosis
  
• A mid-level health manager intervention to promote uptake of isoniazid preventive therapy among people with HIV in Uganda: a cluster randomised trial
  
• Association of underweight status with the risk of tuberculosis: a nationwide population-based cohort study
  
• ​High clustering rate and genotypic drugsusceptibility screening for the newly recommended anti-tuberculosis drugs among global extensively drug-resistant Mycobacterium tuberculosis isolates
  
• Investigating resistance in clinical Mycobacterium tuberculosis complex isolates with genomic and phenotypic antimicrobial susceptibility testing: a multicentre observational study 
  
• Pharmacokinetics and Safety of WHO-Recommended Dosage and Higher Dosage of Levofloxacin for Tuberculosis Treatment in Children: a Pilot Study  
  
• Bedaquiline–Pretomanid–Linezolid Regimens for Drug-Resistant Tuberculosis
  
• Feasibility and Sensitivity of Saliva GeneXpert MTB/RIF Ultra for Tuberculosis Diagnosis in Adults in Uganda
  
• Developing tuberculosis vaccines for people with HIV: consensus statements from an international expert panel
  
• Optimal timing of antiretroviral therapy initiation in children and adolescents with HIV-associated pulmonary tuberculosis
  
• A bacterial phospholipid phosphatase inhibits host pyroptosis by hijacking ubiquitin
  
• Pediatric delamanid treatment for children with rifampicin-resistant TB
  
• Treatment outcomes and safety in children with rifampicin-resistant TB
  
• QT prolongation in the STREAM Stage 1 Trial
  
• Management of rifampicin‐resistant TB: programme indicators and care cascade analysis in South Africa
  
• Pretomanid with bedaquiline and linezolid for drug-resistant TB: a comparison of prospective cohorts
  
• Bedaquiline for multidrug-resistant TB in paediatric patients
  
• Prevalence of Histoplasmosis among Persons with Advanced HIV Disease, Nigeria
  
• Pelvic and central nervous system tuberculosis complicated by a paradoxical response manifesting as a spinal tuberculoma: a case report
  
• Prevention and treatment of infectious diseases in migrants in Europe in the era of universal health coverage
  
• Predictors for Treatment Outcomes in Patients with Multi-drug Resistant Tuberculosis — China, 2018–2020
  
• Metagenomic DNA sequencing to quantify Mycobacterium tuberculosis DNA and diagnose tuberculosis
  
• Massive Hemoptysis in Pulmonary Tuberculosis From Rasmussen Pseudoaneurysm
  
• An optimized method for purifying, detecting and quantifying Mycobacterium tuberculosis RNA from sputum for monitoring treatment response in TB patients
  
• ​Multidrug-Resistant Musculoskeletal Tuberculosis: An Aggressive Clinical, Radiological and Molecular Confirmation With Genotypic Drug Susceptibility Testing Approach
  
• Living with tuberculosis: a qualitative study of patients’ experiences with disease and treatment
  
• Transcontinental spread and evolution of Mycobacterium tuberculosis W148 European/Russian clade toward extensively drug resistant tuberculosis
  
• Improving Estimates of Social Contact Patterns for Airborne Transmission of Respiratory Pathogens
  
• Clinical standards for the assessment, management and rehabilitation of post-TB lung disease
  
• Clinical effects of TB sequelae in patients with COPD
  
• Correlation between lung function tests and peak oxygen consumption in post-TB lung disease
  
• ​​Post-tuberculosis lung health: perspectives from the First International Symposium
  
• Effect of Digital Medication Event Reminder and Monitor-Observed Therapy vs Standard Directly Observed Therapy on Health-Related Quality of Life and Catastrophic Costs in Patients With Tuberculosis
  
• Design principles to assemble drug combinations for effective tuberculosis therapy using interpretable pairwise drug response measurements
  
• Diagnosis of paediatric tuberculosis by optically detecting two virulence factors on extracellular vesicles in blood samples
  
• Assessment of TB underreporting by level of reporting system in Lagos, Nigeria
  
• Early interactions with newly diagnosed TB patients in hospital can support linkage to care
  
• Improving TB case notification and treatment coverage through data use
  
• Knowledge and attitudes towards TB among healthcare workers in Yogyakarta, Indonesia
  
• The impact of COVID-19 on TB: a review of the data
  
• The COVID-19 and TB syndemic: the way forward
  
• Ancient and recent differences in the intrinsic susceptibility of Mycobacterium tuberculosis complex to pretomanid 
  
• Toxicity and toxicokinetic assessment of an anti-tubercular drug pretomanid in cynomolgus monkeys
  
• Male reproductive hormones in patients treated with pretomanid
  
• Assessment of the Carcinogenic Potential of Pretomanid in Transgenic Tg.rasH2 Mice
  
• Linezolid for Drug-Resistant Tuberculosis
  
• Pretomanid in the Treatment of Patients with Tuberculosis in the United States
  
• Bedaquiline–Pretomanid–Linezolid Regimens for Drug-Resistant Tuberculosis
  
• ​Budgetary impact of using BPaL for treating extensively drugresistant tuberculosis
  
• Detecting Mycobacterium tuberculosis Infection in Children Migrating to Australia
  
• Revised Definitions of Tuberculosis Resistance and Treatment Outcomes, France, 2006–2019
  
• Costs of Tuberculosis at 3 Treatment Centers, Canada, 2010–2016
  
• Contributions of GeneXpert® to TB diagnosis in Myanmar
  
• Evaluation of the MolecuTech® REBA MTB-XMDR kit for detection of pre-extensively drug-resistant TB
  
• Diagnosis of paediatric TB using Xpert® MTB/RIF Ultra on fresh respiratory samples
  
• Screening for TB infection: the operator´s impact
  
• Medicinal plant use and adherence problems to TB treatment
  
• TB in the elderly: clinical features and outcomes
  
• Uptake of the lateral flow urine LAM test in Europe and Central Asia
  
• Case-control study of vitamin D status and adult multidrug-resistant pulmonary TB
  
• Factors associated with screening failure and study withdrawal in multidrug-resistant TB
  
• Paediatric TB care in the United Kingdom
  
• ​​Multiple BCG vaccinations for prevention of COVID-19 and other infectious diseases in Type 1 diabetes
  
• ​Physicochemical and Biological Evaluation of Curdlan-Poly(Lactic-Co-Glycolic Acid) Nanoparticles as a Host-Directed Therapy Against Mycobacterium Tuberculosis
  
• Heterogeneous impact of Covid-19 response on tuberculosis burden by age group
  
• Massive Hemoptysis in Previously Treated Pulmonary Tuberculosis: A Case Series
  
• A Case of Pulmonary Tuberculosis, Severe Dengue, and COVID-19 With Venous Thromboembolism in an Indian Male: World's First Case​
  
• Clinical Features and Treatment Outcome of Coronavirus and Tuberculosis Co-Infected Patients: A Systematic Review of Case Reports
  
• Immune evasion and provocation by Mycobacterium tuberculosis
  
• Pulmonary Tuberculosis-Related Ischemic Stroke: A Retrospective Case Control Study
  
• Mycobacterium tuberculosis/Mycobacterium bovis triggered different variations in lipid composition of Bovine Alveolar Macrophages
  
• ​Immune evasion and provocation by Mycobacterium tuberculosis
  
• Proton transfer activity of the reconstituted Mycobacterium tuberculosis MmpL3 is modulated by substrate mimics and inhibitors
  
• ​Prevalence of Hepatitis B Virus and Latent Tuberculosis Coinfection in the United States
  
• Decreasing trend of drug-resistant TB in Italy
  
• Altered drug exposures of first-line TB drugs in a moxifloxacin-containing treatment regimen
  
• Feasibility and acceptability of asynchronous VOT among patients with MDR-TB
  
• Failure or relapse predictors for the STREAM Stage 1 short regimen for RR-TB
  
• Does distance to healthcare facility affect care-seeking for TB-related symptoms in Tanzania?
  
• Implementing 3HP vs. IPT as TB preventive treatment in Pakistan
  
• TB disease patterns by HIV and diabetes status
  
• TB preventive treatment among pregnant women with HIV
  
• Successes and challenges of latent TB screening and treatment in a high-prevalence US region
  
• Increasing and More Commonly Refractory Mycobacterium avium Pulmonary Disease, Toronto, Ontario, Canada
  
• Incidence of Nontuberculous Mycobacterial Pulmonary Infection, by Ethnic Group, Hawaii, USA, 2005–2019
  
• Tuberculosis Among Native Hawaiian and Other Pacific Islander Persons: United States and U.S.-Affiliated Pacific Islands, 2010–2019
  
• Rapid adaptation of a complex trait during experimental evolution of Mycobacterium tuberculosis
  
• Tuberculosis among resident doctors and nurses in a tertiary care hospital: A case-control study
  
• The Collaborative Ocular Tuberculosis Study (COTS) calculator—a consensus-based decision tool for initiating antitubercular therapy in ocular tuberculosis
  
• Predisposing Factors of Tuberculosis Infection in Systemic Lupus Erythematosus Patients: A Single-Center Case-Control Study
  
• Tuberculosis and Its “Troubled Relationship” With Other Diseases
  
• Predicting resistance to fluoroquinolones among patients with rifampicin-resistant tuberculosis using machine learning methods
  
• Factors contributing to the high prevalence of multidrug-resistance/Rifampicin-resistance in patients with tuberculosis: an epidemiological cross sectional and qualitative study from Khabarovsk krai region of Russia
  
• ​Assessment of tuberculosis disease activity in people infected with Mycobacterium tuberculosis and living with HIV: A longitudinal cohort study
  
• Primary Isoniazid Mono-Resistant Pulmonary Tuberculosis in a COVID-19-Positive Male: World's First Case of Its Kind in the Present Pandemic
  
• ​Novel Mycobacterium tuberculosis Complex Genotype Related to M. caprae
  
• Treatment outcomes 24 months after initiating short, all-oral bedaquiline-containing or injectable-containing rifampicin-resistant tuberculosis treatment regimens in South Africa: a retrospective cohort study
  
• Effectiveness of a community-based intervention to prevent childhood TB in Lesotho
  
• Trends in TB and HIV care and treatment cascade, Kenya, 2008–2018
  
• Accelerating TB diagnosis during the COVID-19 pandemic
  
• Prevalence and clinical characteristics of pulmonary TB among pregnant and post-partum women
  
• Isoniazid preventive therapy among child contacts of TB patients, India
  
• Acquired bedaquiline resistance in Karakalpakstan, Uzbekistan
  
• TB-related deaths among adults in Guinea-Bissau
  
• Addressing bedaquiline treatment interruptions in the treatment of drug-resistant TB
  
• Moxifloxacin concentration correlate with QTc interval in rifampicin-resistant tuberculosis patients on shorter treatment regimens
  
• Impact of diabetes mellitus on rifampicin's plasma concentration and bioavailability in patients with tuberculosis: A systematic review and meta-analysis study
  
• Tumor necrosis factor induces pathogenic mitochondrial ROS in tuberculosis through reverse electron transport
  
• Treatment Outcomes Among Pregnant Patients With Multidrug-Resistant TuberculosisA Systematic Review and Meta-analysis
  
• ​Systems of support for foreign-born TB patients and their family members
  
• Hearing aid support for patients with DR-TB in Ethiopia
  
• The impact of diabetes mellitus on pulmonary TB
  
• Causes of loss to follow-up from drug-resistant TB treatment in Khayelitsha, South Africa
  
• Integrating hepatitis C treatment into multidrug-resistant TB care
  
• Portable digital X-ray for TB pre-diagnosis screening in rural communities in Nigeria
  
• Impact of on-site Xpert on TB diagnosis and mortality trends in Uganda
  
• Sequential Imaging Characteristics and Potential Role of F18 Fluorodeoxyglucose Positron Emission Tomography/CT in the Evaluation of Treatment Response in Cases of Spinal Tuberculosis Without Neurological Involvement: Results From a Pilot Study
  
• Low transcriptomic of PTPRCv1 and CD3E is an independent predictor of mortality in HIV and tuberculosis co-infected patient
  
• Concurrent severe pulmonary tuberculosis with Evans syndrome: a case report with literature review
  
• ​CRISPRi chemical genetics and comparative genomics identify genes mediating drug potency in Mycobacterium tuberculosis
  
• A novel class of antimicrobial drugs selectively targets a Mycobacterium tuberculosis PE-PGRS protein
  
• The small-molecule SMARt751 reverses Mycobacterium tuberculosis resistance to ethionamide in acute and chronic mouse models of tuberculosis
  
• Male reproductive hormones in patients treated with pretomanid
  
• Parental TB associated with offspring asthma and rhinitis
  
• Characteristics, risk factors and outcomes of critically ill patients with active TB
  
• ​Does BCG vaccination protect against infection with M. tuberculosis?
  
• Global availability of susceptibility testing for second-line anti-tuberculosis agents
  
• ​Stool testing for pulmonary TB diagnosis in adults
  
• Early line-probe assay using DNA specimens in patients with pulmonary TB
  
• Number needed to screen for TB in clinical, structural or occupational risk groups
  
• Clinical standards for the dosing and management of TB drugs
  
• Multidrug-Resistant Tuberculosis Treatment Outcome and Associated Factors at the University of Gondar Comprehensive Specialized Hospital: A Ten-Year Retrospective Study
  
• CRISPR detection of circulating cell-free Mycobacterium tuberculosis DNA in adults and children, including children with HIV: a molecular diagnostics study
  
• An Unexpected Encounter With Miliary Tuberculosis in a Young Man With a Remote Exposure History
  
• The global impact of household contact management for children on multidrug-resistant and rifampicin-resistant tuberculosis cases, deaths, and health-system costs in 2019: a modelling study
  
• Xpert Ultra testing of blood in severe HIV-associated tuberculosis to detect and measure Mycobacterium tuberculosis blood stream infection: a diagnostic and disease biomarker cohort study
  
• ​CinA mediates multidrug tolerance in Mycobacterium tuberculosis
  
• Potential association between bacterial infections and ischemic stroke based on fifty case-control studies: a systematic review and meta-analysis
  
• Pharmacokinetics and Safety of Bedaquiline in HIV-Positive and Negative Older Children and Adolescents with Rifampicin-Resistant Tuberculosis
  
• Potential implementation strategies, acceptability, and feasibility of new and repurposed TB vaccines
  
• Bacille Calmette-Guérin vaccine reprograms human neonatal lipid metabolism in vivo and in vitro
  
• Trends in rifampicin and isoniazid resistance in patients with presumptive TB
  
• Xpert Ultra in diagnosing extrapulmonary TB: accuracy and trace calls
  
• Performance of the GenoType MTBDRsl in a programmatic setting, South Africa
  
• Systematic TB screening using WHO radiograph categorisation and care outcomes
  
• Risk factors for TB in Australia and their association with delayed treatment completion
  
• Rapid molecular tests for tuberculosis and tuberculosis drug resistance: a qualitative evidence synthesis of recipient and provider views
  
• Anti-tuberculosis treatment strategies and drug development: challenges and priorities
  
• ​Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment.
  
• Linezolid toxicity in patients with drug-resistant tuberculosis: a prospective cohort study.
  
• Delamanid or pretomanid? A Solomonic judgement!
  
• ​Investigation of Clofazimine Resistance and Genetic Mutations in Drug-Resistant Mycobacterium tuberculosis Isolates.
  
• Disadvantage and the Experience of Treatment for Multidrug-Resistant Tuberculosis (MDR-TB).
  
• The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions
  
• Monitoring IgG against Mycobacterium tuberculosis proteins in an Asian elephant cured of tuberculosis that developed from long-term latency
  
• Distribution of Common and Rare Genetic Markers of Second-Line-Injectable-Drug Resistance in Mycobacterium tuberculosis Revealed by a Genome-Wide Association Study
  
• Space-Time Distribution Characteristics of Tuberculosis and Its Socioeconomic Factors in Southern China from 2015 to 2019
  
• Distribution of Common and Rare Genetic Markers of Second-Line-Injectable-Drug Resistance in Mycobacterium tuberculosis Revealed by a Genome-Wide Association Study
  
• Association between cytomegalovirus infection and tuberculosis disease: A systematic review and meta-analysis of epidemiological studies 
  
• Cytomegalovirus acquisition in infancy and the risk of tuberculosis disease in childhood: a longitudinal birth cohort study in Cape Town, South Africa
  
• Increased Risk of Incident Diabetes Among Individuals With Latent Tuberculosis Infection 
  
• ​When it comes to stopping tuberculosis, what is actually “missing”?
• Homeless Shelters: HIV Testing During the Atlanta Tuberculosis Outbreak (2008–2018)
  
• Intestinal Perforation as a Paradoxical Reaction to Tuberculosis
  
• atpE Mutation in Mycobacterium tuberculosis Not Always Predictive of Bedaquiline Treatment Failure
  
• ​Early alveolar macrophage response and IL-1R-dependent T cell priming determine transmissibility of Mycobacterium tuberculosis strains
  
• Evaluation of the latent tuberculosis care cascade among public health clinics in the United States 
  
• Recently developed drugs for the treatment of drug-resistant tuberculosis: a research and development case study
  
• Tuberculosis screening among HIV-positive inpatients: a systematic review and individual participant data meta-analysis
  
• An influence of dew point temperature on the occurrence of Mycobacterium tuberculosis disease in Chennai, India
  
• ​Minnesota refugees diagnosed with tuberculosis disease, January 1993–August 2019
  
• Gene expression signatures identify biologically and clinically distinct tuberculosis endotypes
  
• Sputum lipoarabinomannan (LAM) as a biomarker to determine sputum mycobacterial load: exploratory and model-based analyses of integrated data from four cohorts
  
• Enteropathogen spectrum and effect on antimycobacterial pharmacokinetics among children with tuberculosis in rural Tanzania: a prospective cohort study
  
• Performance of Xpert® MTB/RIF and Xpert® Ultra for the diagnosis of tuberculous meningitis in children
  
• Low BMI increases all-cause mortality rates in patients with drug-resistant TB
  
• Concomitant pulmonary disease is common among patients with extrapulmonary TB
  
• High mortality due to gastrointestinal TB in HIV and non-HIV patients
  
• Finding gaps in routine TB surveillance activities in Bangladesh
  
• Clinical effects of TB sequelae in patients with COPD
  
• ​High-dose rifampin improves bactericidal activity without increased intracerebral inflammation in animal models of tuberculous meningitis
  
• Recurrent subclinical tuberculosis among ART accessing participants: Incidence, clinical course, and outcomes 
  
• Mice infected with Mycobacterium tuberculosis are resistant to acute disease caused by secondary infection with SARS-CoV-2
  
• Reactivation of Tuberculosis in the Setting of COVID-19 Infection
  
• Monitoring IgG against Mycobacterium tuberculosis proteins in an Asian elephant cured of tuberculosis that developed from long-term latency
  
• ​Decrease in Tuberculosis Cases during COVID-19 Pandemic as Reflected by Outpatient Pharmacy Data, United States, 2020   ​
  
• Missed opportunities for diagnosis and treatment in patients with TB symptoms: a systematic review
  
• A structured community engagement strategy to support uptake of TB active case-finding
  
• Prevalence and interpretation of Xpert® Ultra trace results among presumptive TB patients
  
• TB training in Kenya: building capacity for care and prevention
  
• Shorter Treatment for Nonsevere Tuberculosis in African and Indian Children
  
• Geographically dispersed zoonotic tuberculosis in pre-contact South American human populations
  
• IL-10 Receptor Blockade Delivered Simultaneously with Bacillus Calmette–Guérin Vaccination Sustains Long-Term Protection against Mycobacterium tuberculosis Infection in Mice
  
• The Radiographic and Mycobacteriologic Correlates of Subclinical Pulmonary TB in Canada
  
• ​Feasibility of a “Salvage Regimen” Using Home-based Intravenous Meropenem Therapy With a Delamanid/Bedaquilline Containing Regimen in the Management of MDR/XDR Pediatric Tuberculosis
  
• An All-Oral 6-Month Regimen for Multidrug-Resistant TB (the NExT Study): A Multicenter, Randomized Controlled Trial   
  
• Increased Moxifloxacin Dosing Among Patients With Multidrug-Resistant Tuberculosis With Low-Level Resistance to Moxifloxacin Did Not Improve Treatment Outcomes in a Tertiary Care Center in Mumbai, India
  
• Model-Based Efficacy and Toxicity Comparisons of Moxifloxacin for Multidrug-Resistant Tuberculosis
  
• Macrophage global metabolomics identifies cholestenone as host/pathogen cometabolite present in human Mycobacterium tuberculosis infection
  
• Detecting Tuberculosis-Consistent Findings in Lateral Chest X-Rays Using an Ensemble of CNNs and Vision Transformers
  
• ​Antiretroviral therapy timing impacts latent tuberculosis infection reactivation in a Mycobacterium tuberculosis/SIV coinfection model
  
• Kupyaphores are zinc homeostatic metallophores required for colonization of Mycobacterium tuberculosis
  
• Telehealth Reduces Missed Appointments in Pediatric Patients with Tuberculosis Infection
  
• Treatment Outcomes of Childhood Tuberculous Meningitis in a Real-World Retrospective Cohort, Bandung, Indonesia
  
• Overseas Treatment of Latent Tuberculosis Infection in US–Bound Immigrants
  
• ​Time to care-seeking for TB symptoms
  
• Correlation between lung function tests and peak oxygen consumption in post-TB lung disease
  
• The effect of incarceration on TB treatment outcomes
  
• Knowledge, attitudes and practices on childhood TB among healthcare workers
  
• TB testing in HIV-positive patients prior to antiretroviral treatment
  
• Paediatric admissions to a TB hospital: reasons for admission, clinical profile and outcomes
  
• Antiretroviral therapy timing impacts latent tuberculosis infection reactivation in a Mycobacterium tuberculosis/SIV coinfection model
  
• Histone acetylome-wide associations in immune cells from individuals with active Mycobacterium tuberculosis infection
  
• Accurate and rapid prediction of tuberculosis drug resistance from genome sequence data using traditional machine learning algorithms and CNN
  
• Safety and efficacy of non-fluoroscopic endoscopic dilatation of gastrointestinal tuberculosis related strictures
  
• Biomarkers That Correlate with Active Pulmonary Tuberculosis Treatment Response: a Systematic Review and Meta-analysis
  
• Development of a Highly Specific, Selective, and Sensitive Fluorescent Probe for Detection of Mycobacteria in Human Tissues
  
• A Phase I/II randomized trial of H56:IC31 vaccination and adjunctive cyclooxygenase-2-inhibitor treatment in tuberculosis patients
  
• A self-rated health score predicts severe disease and high mortality in patients with pulmonary TB
  
• Treatment outcomes and safety in children with rifampicin-resistant TB
  
• Determinants of treatment outcomes in patients with multidrug-resistant TB
  
• Incomplete contact investigation and risk of developing TB among healthcare professionals
  
• The risk factors of the postoperative poor wound healing in spinal tuberculosis patients: A single centre retrospective cohort study
  
• Safety of treatment regimens containing bedaquiline and delamanid in the endTB cohort 
  
• The role of prisons in disseminating tuberculosis in Brazil: A genomic epidemiology study
  
• Cost-effectiveness of routine adolescent vaccination with an M72/AS01E-like tuberculosis vaccine in South Africa and India
  
• Efavirenz Pharmacokinetics and Human Immunodeficiency Virus Type 1 (HIV-1) Viral Suppression Among Patients Receiving Tuberculosis Treatment Containing Daily High-Dose Rifapentine
  
• Central Nervous System Tuberculosis Presenting With Multiple Ring-Enhancing Lesions: A Diagnostic Challenge
  
• Macrophage global metabolomics identifies cholestenone as host/pathogen cometabolite present in human Mycobacterium tuberculosis infection
  
• A modular and reconfigurable open-channel gated device for the electrokinetic extraction of cell-free DNA assays
  
• ​High-dose rifamycins in the treatment of TB: a systematic review and meta-analysis
  
• Building the Evidence for a Rights-Based, People-Centered, Gender-Transformative Tuberculosis Response: An Analysis of the Stop TB Partnership Community, Rights, and Gender Tuberculosis Assessment
  
• BCG vaccination history associates with decreased SARS-CoV-2 seroprevalence across a diverse cohort of health care workers
  
• ​BCG vaccination in health care providers and the protection against COVID-19
  
• COVID-19 Pandemic Disruption on the Management of Tuberculosis Treatment in Indonesia
  
• ​Tuberculosis in times of COVID-19 
  
• Tuberculosis Infection in Children and Adolescents: Testing and Treatment 
  
• Disease Surveillance Among U.S.-Bound Immigrants and Refugees — Electronic Disease Notification System, United States, 2014–2019
  
• Effect of Mixed Infections with Mycobacterium tuberculosis and Nontuberculous Mycobacteria on Diagnosis of Multidrug-Resistant Tuberculosis: A Retrospective Multicentre Study in China
  
• Multicomponent Strategy with Decentralized Molecular Testing for Tuberculosis
  
• Integrating tuberculosis and noncommunicable diseases care in low- and middle-income countries (LMICs): A systematic review
  
• ​Drug resistant tuberculosis in Afghanistan: We must continue to put people at the centre of treatment
  
• Measles, Tuberculosis Vaccines Could ‘Flatten the COVID-19 Curve’
  
• Association of TyG Index with CT Features in Patients with Tuberculosis and Diabetes Mellitus
  
• Exposure–­safety analysis of QTc interval and transaminase levels following bedaquiline administration in patients with drug-­resistant tuberculosis
  
• Evaluation of the performance of the BD MAX MDR-TB test in the diagnosis of Mycobacterium tuberculosis complex in extrapulmonary and pulmonary samples
  
• A Semimechanistic Model of the Bactericidal Activity of High-Dose Isoniazid against Multidrug-Resistant Tuberculosis: Results from a Randomized Clinical Trial
  
• Value of routine whole genome sequencing for Mycobacterium tuberculosis drug resistance detection
  
• Effectiveness and Cardiac Safety of Bedaquiline-Based Therapy for Drug-Resistant Tuberculosis: A Prospective Cohort Study
  
• Emergence of additional drug resistance during treatment of multidrug-resistant tuberculosis in China: a prospective cohort study
  
• Between Curing and Torturing: Burden of Adverse Reaction in Drug-Resistant Tuberculosis Therapy
  
• Genomic signatures of pre-resistance in Mycobacterium tuberculosis
  
• Early TB case detection by community-based mobile X-ray screening and Xpert testing in Balochistan
  
• Isoniazid preventive therapy in child household contacts of adults with active TB in Bamako, Mali
  
• Educational counselling of patients with combined TB and diabetes mellitus: a randomised trial
  
• Multidrug-resistant Tuberculosis in U.S.-bound Immigrants and Refugees
  
• Neutrophil Dynamics Affect Mycobacterium tuberculosis Granuloma Outcomes and Dissemination
  
• A Framework for Assessing the Impact of Disease Treatment
  
• Why has the incidence of tuberculosis not reduced in London during the COVID-19 pandemic?
  
• Ferroptosis-related gene SOCS1, a marker for tuberculosis diagnosis and treatment, involves in macrophage polarization and facilitates bone destruction in tuberculosis
  
• Avoiding pitfalls in calculating the population attributable fraction of undernutrition for TB
  
• Low serum levels of anti-TB drugs in a high TB setting
  
• Current state of national TB laboratory networks in Europe: achievements and challenges
  
• Tuberculous mastitis in a low-incidence setting: should respiratory physicians be concerned?
  
• VIDAS® TB-IGRA reagents induce a CD4+ and CD8+ T-cell IFN-γ response for both TB infection and active TB
  
• ​A randomised controlled trial to evaluate a medication monitoring system for TB treatment
  
• ​How much does TB screening cost? A systematic review of economic evaluations
  
• Demographic and socio-economic risk factors associated with self-reported TB
  
• Use of interactive messaging to reduce pre-diagnosis loss to follow-up for TB care
  
• Effectiveness of two tobacco cessation methods among TB patients
  
• Opportunities to prevent and manage undernutrition to amplify efforts to end TB
  
• ​National TB prevalence surveys in the COVID-19 era
  
• An Inca trail to the Holy Grail: digital medication adherence support for TB care
  
• ​Treatment Outcome of Tubercular Uveitis in a High TB and HIV Setting: A Prospective Cohort Study   
  
• Sputum microbiota profiles of treatment-naïve TB patients in Uganda before and during first-line therapy
  
• CD4+CCR6+ T cells dominate the BCG-induced transcriptional signature
  
• ​Global estimates of paediatric tuberculosis incidence in 2013–19: a mathematical modelling analysis
  
• Building the Evidence for a Rights-Based, People-Centered, Gender-Transformative Tuberculosis Response: An Analysis of the Stop TB Partnership Community, Rights, and Gender Tuberculosis Assessment
  
• Cut-off Points of Treatment Delay to Predict Poor Outcomes Among New Pulmonary Tuberculosis Cases in Dalian, China: A Cohort Study
  
• Evidence and research gaps identified during development of policy guidelines for tuberculosis
  
• Risk Factors for Poor Outcomes Among Patients with Extensively Drug-Resistant Tuberculosis (XDR-TB): A Scoping Review
  
• Genomic signatures of pre-resistance in Mycobacterium tuberculosis
  
• Population pharmacokinetics of bedaquiline in patients with drug-resistant TB
  
• The effect of new Mycobacterium tuberculosis infection on the sensitivity of prognostic TB signatures
  
• Whole-genome sequencing differentiates relapse from re-infection in TB
  
• The effect of systematic screening of the general population on TB case notification rates
  
• Latent Tuberculosis Infection
  
• ​​Tuberculosis screening among ambulatory people living with HIV: a systematic review and individual participant data meta-analysis
  
• Sociodemographic Characteristics, Comorbidities, and Mortality Among Persons Diagnosed With Tuberculosis and COVID-19 in Close Succession in California, 2020
  
• Meningitis caused by Mycobacterium tuberculosis in a recent immigrant to Canada
  
• An allosteric inhibitor of bacterial Hsp70 chaperone potentiates antibiotics and mitigates resistance   
  
• Lifetime burden of disease due to incident tuberculosis: a global reappraisal including post-tuberculosis sequelae
  
• Toxin secretion and trafficking by Mycobacterium tuberculosis
  
• ​​U.S. medical resident familiarity with national tuberculosis guidelines​
• Cytomegalovirus acquisition in infancy and the risk of tuberculosis disease in childhood: a longitudinal birth cohort study in Cape Town, South Africa
  
• Tuberculosis screening among ambulatory people living with HIV: a systematic review and individual participant data meta-analysis
  
• ​Morbidity and Mortality Among Adults Experiencing Homelessness Hospitalized With COVID-19 
  
• Incidence and Clinical Characteristics of and Risk Factors for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Pregnant Individuals in the United States 
  
• Longitudinal Model-Based Biomarker Analysis of Exposure-Response Relationships in Adults with Pulmonary Tuberculosis
  
• Practical approach to detection and surveillance of emerging highly resistant Mycobacterium tuberculosis Beijing 1071-32-cluster
  
• Tuberculosis Pathways to Care and Transmission of Multidrug-Resistance in India
  
• ​A Rare Case of Sternoclavicular Tuberculosis Diagnosed Using Microchip-Based Polymerase Chain Reaction in a Diabetic Female
• Genomic Profiling of Mycobacterium tuberculosis Strains, Myanmar
  
• Isolation of Novel Mycobacterium Species from Skin Infection in an Immunocompromised Person
  
• Co-Infection with 4 Species of Mycobacteria Identified by Using Next-Generation Sequencing
  
• Population Genomics and Inference of Mycobacterium avium Complex Clusters in Cystic Fibrosis Care Centers, United States
  
• Is a high dose sufficient to achieve high isoniazid exposure in children affected by multidrug-resistant TB?
  
• Impact of the bacillary load on the accuracy of rifampicin resistance results by Xpert® MTB/RIF
  
• UNITE4TB: a new consortium for clinical drug and regimen development for TB
  
• Advancing TB research using digitized programmatic data
  
• ​Pharmacokinetics of high-dose isoniazid in children affected by multidrug-resistant TB
  
• Screening for active and latent TB among migrants in France
  
• ​Need for caution when interpreting Xpert® MTB/RIF results for rifampin resistance among children
  
• Evaluation of a lateral-flow nanoparticle fluorescence assay for TB infection diagnosis
  
• Monocyte-to-lymphocyte ratio as a predictor of TB among people living with HIV
  
• Incremental yield of Xpert® MTB/RIF Ultra over Xpert® MTB/RIF in the diagnosis of extrapulmonary TB
  
• Advancing Health Equity: A Guide to Language, Narrative and Concepts
  
• Clinical standards for the assessment, management and rehabilitation of post-TB lung disease
  
• Mitigating the impact of COVID-19 on tuberculosis and HIV services: A cross-sectional survey of 669 health professionals in 64 low and middle-income countries
  
• Implications of COVID-19 in high burden countries for HIV/TB: A systematic review of evidence
  
• The potential impact of the COVID-19 pandemic on the tuberculosis epidemic a modelling analysis
  
• Prevalence of comorbid tuberculosis amongst COVID-19 patients: A rapid review and meta-analysis   
  
• ​Public Health Action - September 2021​
  
• The impact of COVID-19 on HIV, TB and malaria services and systems for health
  
• The impact of COVID-19 on TB: a review of the data
  
• One year of COVID-19 and its impact on private provider engagement for TB: A rapid assessment of intermediary NGOs in seven high TB burden countries - ScienceDirect
  
• COVID-19 and Pulmonary Mycobacterium Tuberculosis Coinfection
  
• Genetic Profile of Linezolid-Resistant M. tuberculosis Clinical Strains from Moscow
  
• Hear us! Accounts of people treated with injectables for drug-resistant TB
  
• Headway made towards biosignatures for incipient tuberculosis
  
• ​​rpoB Mutations and Effects on Rifampin Resistance in Mycobacterium tuberculosis
  
• Development and Psychometric Testing of the Supportive Care Needs Scale for Patients with Tuberculosis (SCN-TB)
  
• ​Infliximab for Paradoxical Reactions in Pediatric Central Nervous System Tuberculosis
  
• NEOPTERIN EVALUATION IN PATIENTS SUFFERING FROM PULMONARY TUBERCULOSIS
  
• Assessment of prevalence of depression and its associated factors among tuberculosis patients in Ernakulam district, Kerala
  
• Detection of isoniazid, fluoroquinolone, ethionamide, amikacin, kanamycin, and capreomycin resistance by the Xpert MTB/XDR assay: a cross-sectional multicentre diagnostic accuracy study
  
• Spatio-temporal variation in tuberculosis incidence and risk factors for the disease in a region of unbalanced socio-economic development   
  
• The diagnostic performance of novel skin-based in-vivo tests for tuberculosis infection compared with purified protein derivative tuberculin skin tests and blood-based in vitro interferon-γ release assays: a systematic review and meta-analysis
  
• Causes of multidrug-resistant tuberculosis from the perspectives of health providers: challenges and strategies for adherence to treatment during the COVID-19 pandemic in Brazil
  
• Concomitant Pulmonary Tuberculosis Impair Survival in Advanced Epidermal Growth Factor Receptor (EGFR) Mutant Lung Adenocarcinoma Patients Receiving EGFR-Tyrosine Kinase Inhibitor
  
• Airborne Immunization against Tuberculosis
  
• Detection and quantification of Mycobacterium tuberculosis antigen CFP10 in serum and urine for the rapid diagnosis of active tuberculosis disease
  
• Treatment of spinal tuberculosis in rabbits using bovine serum albumin nanoparticles loaded with isoniazid and rifampicin
  
• Host- and age-dependent transcriptional changes in Mycobacterium tuberculosis cell envelope biosynthesis genes after exposure to human alveolar lining fluid
  
• Cross-sectional assessment of tuberculosis and HIV prevalence in 13 correctional facilities in Zambia
  
• ​Is the tuberculosis response another casualty of COVID-19?
  
• Effect of HIV-1 infection on T-Cell-based and skin test detection of tuberculosis infection
  
• A qualitative study of perspectives on access to tuberculosis health services in Xigaze, China
  
• Derivation and external validation of a risk score for predicting HIV-associated tuberculosis to support case finding and preventive therapy scale-up: A cohort study
  
• Notes from the Field: Tuberculosis Outbreak Linked to a Contaminated Bone Graft Product Used in Spinal Surgery — Delaware, March–June 2021
• Capturing patient-reported and quality of life outcomes with use of shorter regimens for drug-resistant tuberculosis: mixed-methods substudy protocol, TB PRACTECAL-PRO​
• Molecular basis for DarT ADP-ribosylation of a DNA base 
  
• Blood transcriptomics reveal the evolution and resolution of the immune response in tuberculosis 
  
• Research Spotlights Significance of Social Support in TB Treatment 
  
• Computer-aided X-ray screening for tuberculosis and HIV testing among adults with cough in Malawi (the PROSPECT study): A randomised trial and cost-effectiveness analysis 
  
• In Vitro Miniaturized Tuberculosis Spheroid Model
  
• 100 years of Mycobacterium bovis bacille Calmette-Guérin
  
• Immune Control of Tuberculosis by IFN-γ-Inducible LRG-47
  
• ‘If not for this support, I would have left the treatment!': Qualitative study exploring the role of social support on medication adherence among pulmonary tuberculosis patients in Western India 
  
• BCG re-vaccination in Malawi: 30-year follow-up of a large, randomised, double-blind, placebo-controlled trial
  
• Follow-up of a BCG trial after 30 years: what lessons have we learned?
  
• ​Molecular Epidemiology Study of Mycobacterium Tuberculosis Complex
  
• A data compendium of Mycobacterium tuberculosis antibiotic resistance
  
• Tuberculosis Death Epidemiology and Its Associated Risk Factors in Sabah, Malaysia
  
• Ang II-Induced Hypertension Exacerbates the Pathogenesis of Tuberculosis
  
• Easier cure for resistant TB
  
• ​Mycobacteriophage–antibiotic therapy promotes enhanced clearance of drug-resistant Mycobacterium abscessus
  
• Social and health factors associated with unfavourable treatment outcome in adolescents and young adults with tuberculosis in Brazil: a national retrospective cohort study
  
• Tuberculosis preventive treatment in people living with HIV—Is the glass half empty or half full?
  
• Tuberculosis preventive therapy for people living with HIV: A systematic review and network meta-analysis
  
• Economic and modeling evidence for tuberculosis preventive therapy among people living with HIV: A systematic review and meta-analysis
  
• ​The long-running issues of tuberculosis
  
• Economic impact of tuberculosis mortality in 120 countries and the cost of not achieving the Sustainable Development Goals tuberculosis targets: a full-income analysis
  
• The incalculable costs of tuberculosis
  
• Combined Pulmonary Tuberculosis with Pulmonary and Pleural Cryptococcosis in a Patient Receiving Ruxolitinib Therapy
  
• Relational Dynamics of Treatment Behavior Among Individuals with Tuberculosis in High-Income Countries: A Scoping Review
  
• Linezolid-induced black hairy tongue in a patient with multidrug-resistant tuberculosis: A case report
  
• Willingness to seek medical care for tuberculosis and associated factors among the elderly population in Shenzhen: a cross-sectional study
  
• ​​Economic impact of tuberculosis mortality in 120 countries and the cost of not achieving the Sustainable Development Goals tuberculosis targets: A full-income analysis
  
• ​Tuberculosis in an infant with Hirschsprung-associated enterocolitis: a case report
  
• The Transcription Factor Rv1453 Regulates the Expression of qor and Confers Resistant to Clofazimine in Mycobacterium tuberculosis
  
• Profiles of Volatile Biomarkers Detect Tuberculosis from Skin
  
• Rapid discrimination between tuberculosis and sarcoidosis using next-generation sequencing
  
• The Magnitude of MTB and Rifampicin Resistance MTB Using Xpert-MTB/RIF Assay Among Tuberculosis Suspected Patients in Gedeo Zone, Southern Ethiopia
  
• Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990–2019: results from the Global Burden of Disease Study 2019
  
• Responding to Market Failures in Tuberculosis Control
  
• Predictors of unfavorable responses to therapy in rifampicin-sensitive pulmonary tuberculosis using an integrated approach of radiological presentation and sputum mycobacterial burden
  
• Diabetes and Tuberculosis Link Quantified​